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Background: It is not always possible to collect information about health from patients, so
information from proxies (relatives and others) is used to aid medical decision-making, but
there has been no formal evaluation of the reliability of their reports. The aim of this study
was to analyse the reliability and validity of the St. George’s Respiratory Questionnaire
(SGRQ) answered by proxies and to determine their accuracy as raters.
Methods: Stable symptomatic male COPD patients and relatives living in the same house
independently completed the same version of the SGRQ.
Results: Forty-six male patients were studied; age 72.177.3 years, pre-bronchodilator
FEV1 37.9714.7% predicted, 30.4% on long-term oxygen therapy. Internal consistency
(Cronbach’s a) was over 0.73 for all domains and 40.9 for the total score. Their scores
correlated with dyspnoea (r ¼ 0:3020:45) and FEV1 (r ¼ 0:420:61). The proxies could
distinguish between levels of disease severity, but with a weaker discriminant power
compared to patients. Seventy-two per cent of proxies over-reported the degree of the
patient’s overall health status impairment, especially at mild–moderate scores. Proxies
showed weaker correlations at the more severe scores.
Conclusions: The SGRQ was reliable and valid when administered to relatives of male
COPD patients; however due to the systematic over-reporting of the level of the patient’s
health status impairment, caution should be applied whilst trying to use proxies as
surrogates for male COPD patients.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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The assessment of a patient’s health forms an important
part of clinical decision making. Ideally, patients should be
the respondents when assessing their health, since they
experience the impact of disease on their daily life. It is not
always possible to collect health status data directly from
patients, however, and clinicians often have to manage the
patient based on information provided by relatives. This
may occur especially in patients who are unable to answer
because of advanced age, cognitive disorder or impaired
clinical condition. The use of assessments provided by
relatives is a common daily practice, but there has been
no scientific evaluation of the reliability and validity of
reports of COPD patients’ health and limitation of daily
activity made by proxies.
Questionnaire assessment of health status in COPD
provides additional information to that obtained with
physiological measures—which correlate only moderately
with health-related quality of life.1,2 Disease-specific health
status questionnaires have proven ability to discriminate
between different levels of COPD severity.1 They provide a
standardised method of obtaining clinical information from
a patient and can summarise the effects of the disease into
one overall score. For this reason, they can provide a
systematic way to compare patient and proxy assessments of
health status.
The reliability of proxy raters has been examined in
stroke, cancer, psychiatric disorders and recently in sleep-
disordered breathing.3–5 Proxies, including relatives, care-
givers and health workers, tend to overestimate the degree
of patient health status impairment in all dimensions
evaluated.6–10 Levels of agreement between patients and
proxies’ scores range from 40% to 75%6–8; physical domains
correlate better than psychological aspects.11,12 Few studies
have assessed the psychometric properties of questionnaires
completed by proxies to test whether they are valid and
perform in the same way as in patients.
Such tests are always needed when a questionnaire is
used in a new application, such as by proxies.13
One study has been reported in COPD, but with no
evaluation of the internal consistency and validity of the
questionnaire when answered by proxies.14
The objective of the current study was to validate the St.
George’s Respiratory Questionnaire (SGRQ) for use by
proxies and to determine whether differences exist in the
assessment of health status provided by patient or proxy.Methods
A study was carried out in COPD patients, and their
relatives, recruited from the respiratory outpatient depart-
ment of a university hospital. The study was approved by the
Dos de Maig hospital ethical committee and oral consent was
obtained. Eligibility criteria included: clinical diagnosis of
COPD, history of current or past smoking, no exacerbation
requiring treatment in the previous four weeks and
dyspnoea at least level one on the American Thoracic
Society (ATS) dyspnoea questionnaire, which is a modified
version of the Medical Research Council (MRC) dyspnoea
scale, that includes 4 levels of dyspnoea: grade 0, nottroubled by shortness of breath except with strenuous
exercise; grade I, has trouble when hurrying or walking up a
slight hill; grade II, walks slower or has to stop when walking
at own pace on level ground; grade III, stops after walking
100 yards, is too breathless to leave the house or is
breathless when dressing.15,16 Patients with other lung
diseases or dyspnoea attributed to heart disease were
excluded. Proxies included any relatives living in the same
house. Other than gender and relationship to the patient, no
other details were obtained from the proxies. During the
clinic visit, patients and relatives both completed the same
version of the SGRQ under the supervision of an interviewer
without any discussion between them.
If there were any difficulties in self-administration, this
was done by interview. Three trained physicians partici-
pated in administering the questionnaires. It was read-
ministered to the patient and the same proxy within 2
weeks.
The clinical status of patients was evaluated concurrently
with the measurement of health status. Spirometry was
accepted if performed in the stable state within 3 months of
the interview. Measurements were made pre-bronchodila-
tor. Post-bronchodilator measurements were not available in
all patients, so the analyses used the pre-bronchodilator
values. ATS standard criteria and Roca reference values
were used.17 All patients had evidence of airflow obstruction
with an FEV1/FVC ratio o70%. To categorise the severity
of obstruction, we used the cut-offs points between
severity stages recommended by GOLD: I FEV1 X80%; II
50% pFEV1o80%; III 30%pFEV1 o50%; IV FEV1o30% or
FEV1o50% plus chronic respiratory failure.18
The SGRQ is a standardised airways disease-specific
questionnaire.19,20 It contains 50 items divided into 3
domains: Symptoms (8 items), Activity (16 items) and
Impacts (26 items). A total score is also calculated. Scores
range from 0 to 100, zero indicating no impairment of health
status. We used the same version for both proxies and
patients. The proxies were instructed to answer based on
how they thought that the patient would perceive his/her
daily living. Validation details of the dyspnoea rating and
SGRQ are included in Refs.1,15,16,19,21Statistical analysis
Descriptive statistics were used to characterise the study
population. Internal consistency was assessed using Cron-
bach’s a reliability coefficient and repeatability was
calculated using the intraclass correlation between the first
and second administration. Validity was evaluated using
Pearson (r) and Spearman (r) coefficients to correlate SGRQ
scores with clinical and functional measures.
Difference between correlations in proxies and patients
were tested using the Steiger z-test. Differences in mean
scores on each domain across GOLD stages and dyspnoea
levels were examined using one-way analysis of variance
(ANOVA). Post-hoc analysis to assess differences between
groups was carried out using Tamhane’s T2 test.
Differences between proxies’ and patients’ mean scores
values and in mean difference scores according the type of
proxy were evaluated using paired t- and independent
t-tests, respectively.
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proxies was tested using regression models. Statistical
analyses were performed using SPSS version 10.0 and values
of Po0:05 were considered statistically significant. Using
Cohen’s general guidelines and a standard statistical ap-
proach when comparing two groups with an a of 0.05 and a
power of 0.8 anticipating a moderate-to-large effect size, the
sample size was adequate.22 The SGRQ scores obtained during
the first interview were used for the majority of the tests,
apart from repeatability, in order to avoid the influence of
any possible discussion between patients and proxies.
Results
The number of eligible patients who were approached was
59: two patients declined to participate, one was not
included because of proxy reluctance, eight were ineligible
because they lived alone and one had a severe psychiatric
disorder. One female was originally recruited, but excluded
from the final analysis as she was the only female, reflecting
the very low proportion of women with COPD in Spain.
In total, 46 patients with their relatives were enrolled.
None had completed any health questionnaires before. The
proxies were: 80.4% the spouse, 19.6% others. Thirty-four
proxy-patient pairs completed the questionnaire on two
occasions (mean of 6.3 days between administrations). Twelve
proxy-patient pairs could not be contacted further or attend
the clinic within the necessary 2-week follow-up period.
All statistical analyses were carried out using the 46
patients’ data unless otherwise stated. The mean SGRQ
scores and clinical characteristics of the 12 pairs who
answered once did not differ statistically from the 34 pairs
answering twice (Table 1).
Reliability and validity in proxies
Descriptive and reliability characteristics of proxies’ SGRQ
scores are compared with those of patients in Table 2. The
Activity domain had the highest proportion of worst-possible
score compared to other dimensions, in both patients and
proxies.Table 1 Characteristics of population.
Answering twice (n ¼ 3
Age 72.377.3
BMI 27.874.8
FEV1 (%) 36.8714.2
Exacerbations last year 1 (IQR 3)
Oxygen therapy 26.5%
Type of proxy 79.4% partner
20.6% others
Ex-smokers 88.2%
ATS dyspnoea grades I 32.4%, II 44.1%, III 23.
Charlson co-morbidity index 2.6 (IQR 2)
BMI—Body Mass Index; IQR—inter-quartile range.
t-test.
yMann–Whitney.
zw2.The highest rate of best possible score was observed in
the Symptoms domain in patients and in the Impacts
dimension in proxies. The internal consistency of both
proxies’ and patients’ total score was good (a40:9) and
higher than that of the domains (a ¼ 0:7320:85). The mean
difference in SGRQ scores provided by the proxies between
the first and second administrations was o1.5 units. The
intraclass correlation for the repeated measurements was
40.7 in all domains (Table 3).
The proxies’ SGRQ total and domain scores showed a
similar correlation with dyspnoea and FEV1 to that found
with the scores from the patients, except for the symptoms
score (Table 4). Activity showed the highest correlation with
dyspnoea and FEV1 in both patients and proxies. ANOVA
showed a significant association between SGRQ and GOLD
severity stage, patients Po0:0001, F ¼ 9:89; proxies
Po0:0001, F ¼ 9:35 (Fig. 1). There was also an association
between SGRQ score and dyspnoea grade; patients
Po0:002, F ¼ 6:99; proxies P ¼ 0:019, F ¼ 4:34 (Fig. 2).
The degree of association between SGRQ score and GOLD
stage was similar in patients (model R2 ¼ 0:32, Po0:001)
and proxies (model R2 ¼ 0:30, Po0:001).
The degree of association between SGRQ score and
dyspnoea was: patients (model R2 ¼ 0:24, Po0:01); proxies
(model R2 ¼ 0:17, Po0:013).
Post-hoc analysis showed differences in SGRQ scores
between GOLD stages II and IV in both patients (Po0:001)
and proxies (P ¼ 0:02), (Fig. 1). There were also differences
between dyspnoea levels I and II (P ¼ 0:04) and I and III
(P ¼ 0:002) in the patients and between level I and III in the
proxies (P ¼ 0:02) (Fig. 2).
There were no differences in score between patients and
proxies dependent on the type of proxy (spouses vs. others)
(P40:91). For this reason, responses from spouses and
others were combined for the all other analyses.
Agreement between proxies and patients
The SGRQ scores from the proxies were higher in all
dimensions. Differences between patient and proxy mean
scores ranged from 6.3 to 10.4 units and were statistically4) Answering once (n ¼ 12) P-value
71.377.4 0.68
26.975.3 0.59
41.54716.4 0.36
1.5 (IQR 2) 0.25y
41.7% 0.297z
83.3% partner 0.651z
16.7% others
75% 0.254z
5% I 41.7%, II 33.3%, III 25% 0.838z
2.3 (IQR 2) 0.41y
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Table 2 Distribution and reliability of patient and proxy SGRQ scores.
Symptoms Activity Impacts Total
Patient Proxy Patient Proxy Patient Proxy Patient Proxy
Mean7SD 45.4722.1 51.6720.9 63.9723.4 74.3724.1 37.2719.4 46.8720.2 46.6718.4 55.6718.7
t- and P-value 1.47 (0.15) 3.78 (0.001) 3.58 (0.001) 3.89 (o0.001)
ay 0.73 0.74 0.85 0.83 0.84 0.82 0.91 0.91
Missing data (%) 9.3 8.8 7.6 3.6 5.9 2.6 7.0 3.9
Ceiling effectz (%) 4.3 2.2 2.2 2.2 2.2 4.3 2.2 0
Floor effecty (%) 2.2 0 6.5 13 0 0 0 0
Difference between patient and proxy using paired t-test. Degrees of freedom 45.
ya Cronbach’s reliability coefficient.
zCeiling effect—best possible score (i.e. SGRQ score ¼ zero units).
yFloor effect—worst possible score (i.e. SGRQ score ¼ 100 units).
Table 3 Test–retest reliability in proxies SGRQ scores
(n ¼34).
First test Second test ICC
(units7SD ) (units7SD)
Symptoms
Patients 44.66722.71 46.14723.41 0.91
Proxies 50.34720.63 51.6717.94 0.72
Activity
Patients 63.85722.34 66.52721.43 0.93
Proxies 77.13719.48 75.88717.87 0.82
Impacts
Patients 36.21717.79 34.22717.12 0.88
Proxies 47.69719.08 46.63717.64 0.82
Total
Patients 45.98717.00 45.74715.99 0.94
Proxies 56.75716.82 56.15715.57 0.85
SD: Standard deviation; ICC: Intraclass correlation.
Intra-class correlation between the first and second
administration of the SGRQ.
Table 4 Relationship between clinical variables and
health status domains in proxies and patients.
FEV1 % predicted (r) Dyspnoea (r)
Patient Proxy Patient Proxy
Symptoms 0.32* 0.25z 0.36 0.10z
Activity 0.54 0.61 0.57 0.45
Impacts 0.40* 0.40* 0.38 0.30*
Total 0.49 0.50 0.50 0.32*
All P-values are o0.01 except those marked with *Po0.05
for correlation coefficients. zP-value not significant. r:
Pearson’ r-value; r: Spearman’s r.
Figure 1 Box plots of patients’ and proxies’ SGRQ total scores
grouped using COPD GOLD stages. Solid bar is median. The outer
edges of the box plot are 25% and 75% points and the whiskers
are the minimum and maximum values. Paired t-test showed
that the SGRQ score was significantly higher in proxies
compared to patients in stages II (P ¼ 0:046) and IV (P ¼ 0:013).
C. Santiveri et al.442significant for all domains, except symptoms (Table 2,
Fig. 3). The proportion of proxies who over-reported
compared to the patients was 76% for the Activity domain
and 72% for the total score. In this subgroup, the difference
score was clinically meaningful (over four-point difference)
in 90% proxy-patient pairs for the total score. At all levels of
airway obstruction and all grades of dyspnoea, the proxies’
scores were higher than the patients’ scores (Fig. 3).
There were significant linear correlations between patient
and proxy score for Symptoms (r ¼ 0:53, Po0:0001) and
Activity (r ¼ 0:65, Po0:0001) but the correlations with the
Impacts and total scores were not linear. Polynomial
regression showed a significant non-linear component
(Po0:0001) in both cases. The plot for the total score shows
that above a score of 40–50 units for the patients’ SGRQ
score the relationship became flat (Fig. 4). The impacts
score behaved similarly to the total score.
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The primary objective of this study was to analyse the
psychometric properties of the St. George’s Respiratory
Questionnaire answered by proxies and to evaluate the
degree of agreement between the proxies and the patients.
The major findings were as follows: First, we found that
the SGRQ had good reliability, repeatability and discriminant
validity when used by proxies as respondents. Second, in the
proxies, SGRQ scores showed a weaker correlation with
clinical variables compared to those in patients. Third,
proxies’ SGRQ scores were consistently higher (worse) on all
domains compared with those reported by the patients.
Fourth, statistically and clinically significant differences in
SGRQ scores were noted for all domains, with proxies rating
the patients as having a more impaired health status than
the patients themselves. This difference was smallest within
the Symptoms domain.Figure 2 Box plots of patients’ and proxies’ SGRQ total scores
grouped using dyspnoea ratings. Solid bar is median. The outer
edges of the box plot are 25% and 75% points and the whiskers
are the minimum and maximum values. Paired t-tests showed
significant differences between patient and their proxy in grade
I (P ¼ 0:02) and II (P ¼ 0:01).
Figure 3 Differences in health status ratings between the proxy a
(proxy-patient). The error bars are 95% confidence intervals. A high
patients Sym (symptoms); Act (activity); Imp (impacts); Tot (total).Analysis of the reliability of the SGRQ scores in proxies
and patients showed quite good internal consistency
(Cronbach’s a40.7 for domain scores), which is judged
acceptable for group level comparisons. In the total score,
the a-value exceeded the level of 0.9 which is the minimum
criterion for individual comparisons.20,21 Repeatability of
proxy scores was good for all scales, with an ICC coefficient
40.7 which is an acceptable test–retest reproducibility
criterion. It is noteworthy that the repeatability of the SGRQ
scores in the proxies was lower than in the patients. This
suggests that the cues or reference points that they used
when choosing to respond to any particular item were less
stable than in the patients.
The correlations between the proxies’ SGRQ scores and
the clinical indicators supported the clinical validity of
proxies as respondents. FEV1 and dyspnoea correlated most
strongly with the SGRQ activity score as previously reported
in patients.1,20,21
However, compared to the patients, the correlations
between SGRQ scores in the proxies were lower for
dyspnoea than FEV1. This could be a chance observation ornd the patient. The Y-axis shows the mean difference in score
er value indicates that the proxies scores were higher than the
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Figure 4 Relationship between proxy and patient SGRQ total
scores. The second order (non-linear) component was signifi-
cant at Po0:0001 showing that at higher levels of health
impairment, the proxies ‘scores did not increase as the patients
scores increased. The R2-value for the overall model was 0.63.
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impairment at the milder end of the spectrum.
The pattern and magnitude of association between SGRQ
scores and the clinical variables was similar to that previously
described in patients.1,21 The impacts score did not correlate
as highly with FEV1 and dyspnoea in either group of
respondents compared to previous studies. This might have
been due to our older population who may accept impairment
as part of their aging process.21 The proxies were sensitive to
differences of health status across different levels of disease
activity, rating patients as having a more impaired health
status as disease severity worsened. This finding was
consistent, whether GOLD COPD stage or ATS dyspnoea grade
was used to measure disease severity; however, the
discriminant ability of the proxy scores was weaker on
virtually all tests compared to the patients’ scores.
Systematic differences were found between self- and
proxy-evaluated health status. The proxies reported the
patient’s health status to be more impaired than the
patients themselves. This was statistically significant in all
domains, except Symptoms. This finding is similar to those
from previous studies in other chronic diseases, which
showed lower levels of disagreement in physical aspects of
the conditions.11,12 The lowest inter-rater agreement was in
the Impacts domain which probably reflects the more
subjective nature of this dimension. The mean difference
between the SGRQ total scores exceeded the four-point
difference reported to be clinically significant.20 There was
an overestimation of health status impairment at mild–mo-
derate levels of severity. At higher levels, there was a
weaker relationship between proxy and patient scores. This
was probably due to the tendency for proxies to score higher
(worse) than patients, so there was less capacity for them to
discriminate between health states at the severe end of the
spectrum.
A number of reasons may have contribute to the inter-
rater discrepancy: observer factors such as the patient’s
denial of the impact and consequences of COPD, adjustment
of his expectations or exaggeration of the impairment by
proxies3 and methodological factors such as the choice of
the statistic to measure agreement and the use of a
questionnaire by proxies that was specifically designed to
be used by patients. Ultimately, the patients’ perspective is
likely to be more valid since there is no other accepted gold
standard for the measurement of health status.4
The type of proxy did not influence the scores but this
may have been due to the small number of individuals in
each group. We did not collect any details such as age,
education background, cognitive function or health status in
proxies that might have influenced the inter-rater varia-
bility, however, the health status of the patient and the
domain under consideration is reported to be a more
important source of disagreement than the raters’ back-
ground characteristics.13
The results of this study are consistent with several reports
in other chronic diseases that have used proxy assessments.
Proxies tend to rate patients as more impaired than patients
rate themselves.4–10,13,14,23,24 In cancer and stroke patients,
there is a 40–75% level of agreement with the lowest level of
concordance on the emotional domain.6,23,24
Lower levels of agreement have been reported among
severely affected subjects, as shown in our study. This couldbe related to an adaptative psychological functioning to
maintain optimum quality of life.24
Agreement between raters in COPD has been examined in
one study in which the same SGRQ and Sickness Impact
Profile versions were administered to patients and proxies.14
Relatives tended to report worse health status impairment
than patients in the Impacts domain, but the authors
provided no data on the levels of agreement.
They also did not assess the psychometric properties of
the SGRQ when completed by relatives, or perform any
validity tests. The study population was recruited through
advertising—which introduces a selection sample bias.
Finally, data on clinical stability were not provided and
tests were mailed to participants without supervision.
Our study has some limitations. First, although we had a
relatively small sample size, a full range of SGRQ scores was
observed and a larger study would simply have reduced the
confidence intervals around the difference. Second, its
design did not allow us to test the sensitivity of the proxies’
SGRQ scores to changes in disease activity. Third, we did not
study patients with mild disease, but this is a minor
limitation since the use of proxies would be more frequent
in severe patients. Fourth, the analysis of only male patients
and the predominance of females in proxies, might bias the
results. Females perceive a more impaired health status
when compared to matched male subjects in sleep-breath-
ing disorders and healthy populations.3,25 Our results might
be extrapolated to other cultural settings, but the different
family role and engagement in patient’s care in different
societies should be taken into account when evaluating
agreement between patients and proxies.
In conclusion, the results indicate that the SGRQ, when
used by proxies, has adequate psychometric properties.
However, proxies appear systematically to report worse
health impairment. This has important implications for the
use of information about the level of disability and impaired
wellbeing provided by relatives in routine practice. It is
possible that they consistently overestimate the patients’
level of impairment when questioned by the patients’
physician. Therefore, physicians need to be cautious in
interpreting their data when using proxy respondents. In
clinical practice a comparison of both ratings could help
identify areas of disagreement to improve psychological
support, particularly when approaching end of life decisions,
and to develop educational strategies.
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